+ All Categories
Home > Documents > Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander,...

Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander,...

Date post: 19-Jan-2016
Category:
Upload: eugene-coup
View: 212 times
Download: 0 times
Share this document with a friend
55
Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department of Clinical Physiology Lund University
Transcript
Page 1: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Dysfunctional but viable myocardium

Ischemic heart disease assessed by MRI and SPECT

Martin Ugander, MD

Department of Clinical Sciences, Lund

Department of Clinical Physiology

Lund University

Page 2: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Supervisor: Håkan Arheden, MD, PhD

Clinical Physiology, Lund

Co-supervisor: Peter Cain, MBBS, PhD

Wesley Heart Clinic, Brisbane, AU

Funding:• Swedish Research Council• Swedish Heart Lung Foundation• Faculty of Medicine at Lund University• Region of Scania

Page 3: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Aim

• To further elucidate the pathophysiology of dysfunctional but viable myocardium in patients with ischemic heart disease.

Page 4: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Outline of Studies

• Study I - Method for quantitative MRI & SPECT

• Study II - Wall thickening vs. Infarct transmurality

• Study III - LVEF vs. Infarct size

• Study IV - Time course of perfusion & function

after revascularization

Page 5: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Study I

Quantitative polar representation of left ventricular myocardial perfusion, function and viability using SPECT and cardiac magnetic resonance: initial results

Cain PA, Ugander M, Palmer J, Carlsson M, Heiberg E, Arheden H.

Clin Physiol Funct Imag 2005 (25) 215-222

Page 6: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Background

• Clinical management of CAD involves complex assessment of the extent and severity of changes in function, perfusion and viability.

• No adequate research tools for quantitative assessment exist.

Page 7: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Aims

• To explore the feasibility of integrative quantitative representation of LV perfusion, function and viability in polar plots.

• To determine agreement between visual scoring and quantitative measures.

Page 8: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

• 10 patients scheduled for CABG– rest/stress SPECT– Cine and delayed enhancment CMR

• Quantification with in-house software

• Comparison with visual scoring using Kendall’s coefficient of concordance (W)

Page 9: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

Page 10: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 11: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Results

Page 12: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Results

Kendall’s W: 1.0 (p<0.001) 0.85 (p<0.001)

Page 13: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Conclusions

• Side-by-side quantitative polar representation of LV perfusion, function and viability is feasible and may aid in the complex assessment of these parameters.

• The agreement between quantitative measurement and visual scoring was very good.

Page 14: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Study II

Infarct transmurality and adjacent segmental function as determinants of wall thickening in revascularized chronic ischemic heart disease

Ugander M, Cain PA, Perron A, Hedström E, Arheden H.

Clin Physiol Funct Imag 2005 (25) 209-214

Page 15: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Background

• Regional LV function in patients with IHD may be influenced by many factors.

Page 16: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Aims

• To explore how regional wall thickening in patients with chronic IHD is affected by both infarct transmurality and the function of adjacent segments.

• To compare with results from healthy subjects.

Page 17: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

• 20 patients– 6 months after revascularization– Cine CMR– Delayed enhancement CMR

• 20 matched controls– Cine CMR

Page 18: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 19: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 20: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 21: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 22: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Multivariate analysis of parameters contributing to

wall thickening t p

Infarct transmurality -4.5 <0.001

Number dysf. adjacent seg. -22.9 <0.001

Page 23: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Conclusion

• The number of dysfunctional adjacent segments is a greater determinant than infarct transmurality on regional wall thickening.

• Infarction is difficult to assess by resting function alone.

• DE CMR is an important tool in this setting.

Page 24: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Study III

A maximum predicted left ventricular ejection fraction in relation to infarct size in patients with ischemic heart disease

Ugander M, Ekmehag B, Arheden H.

Submitted

Page 25: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Background

• An understanding of the relationship between LVEF and infarct size is important when assessing the potential benefit of revascularization in patients with IHD.

Page 26: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Aims

• To explore the relationship between LVEF and IS.

• To determine a maximum predicted LVEF for a given IS.

Page 27: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

• 297 patients clinically referred for viability assessment by CMR

• LVEF

• Infarct size (% LVM)

Page 28: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

Infarct size (%LVM)

LVE

F (

%)

A

θ BC

Page 29: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Patient characteristics (IHD)

Page 30: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Distribution of infarctions

Page 31: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Distribution of number of coronary artery vessel

territories

Page 32: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Results

Page 33: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Cine Contrast

LVEF=29% IS=36%

2ch

4ch

Page 34: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Cine Contrast

LVEF=25% IS=6%

2ch

4ch

Page 35: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Conclusions

• LVEF cannot be used to estimate IS.

• IS cannot be used to estimate LVEF.

• LVEF can be used to estimate a maximum predicted IS.

• IS can be used to estimate a maximum predicted LVEF.

Page 36: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Study IV

Influence of the presence of chronic non-transmural myocardial infarction on the time course of perfusion and functional recovery after revascularization.

Ugander M, Cain PA, Johnsson P, Palmer J, Arheden H.

Manuscript

Page 37: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Background

• The time course of recovery of LV function and perfusion after revascularization is not fully understood.

Page 38: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Aims

• To study the effect of presence of infarction on the time course of recovery of perfusion and function after elective revascularization.

Page 39: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Methods

• 15 patients (inclusion ongoing)– first time elective CABG (n=13) or PCI (n=2)

• Imaging– rest/stress SPECT– cine and delayed enhancement CMR– Before revasc., 1 & 6 months after revasc.

Page 40: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Patient characteristics

• 14 men, 1 woman

• mean age 68 years (range 52-84)

• 3VD n=6

• 2VD n=6

• 1VD n=3

• LVEF = 49 10%

Page 41: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Distribution of infarct transmuralities

Page 42: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 43: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Conclusions

• Dysfunctional segments without infarction improved both perfusion and function at 1 month.

• Segments with infarction showed improved perfusion at 1 month and improved function at 6 months.

• This may reflect more severe ischemic burden in segments with infarction.

Page 44: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Summary

• Study I - Method for quantitative MRI & SPECT

• Study II - Wall thickening vs Infarct transmurality

• Study III - LVEF vs Infarct size

• Study IV - Time course of perfusion & function

after CABG

Page 45: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Conclusion

• It is important to perform quantitative assessment of function,perfusion and viability in combination when studying the pathophysiology of dysfunctional but viable myocardium in IHD.

Page 46: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

www.med.lu.se/cmr

Martin Ugander, MD, PhD-student

Ann-Helen Arvidsson, tech

Erik Hedström, PhD

Marcus Carlsson, MD, PhD-student

Christel Carlander, tech

Håkan Arheden, MD PhD

Karin Markenroth, PhD

Bo Hedén, MD PhDHenrik Engblom, MD, PhD-student

Einar Heiberg ,PhD

Henrik Mosén, MD, PhD

Erik Bergvall, MSc, PhD-student

Page 47: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 48: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

The ischemic cascade

Page 49: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 50: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 51: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 52: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Mahrholdt et al2005 Eur Heart J

Page 53: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 54: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Page 55: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.

Recommended